Corvus Pharmaceuticals, Inc. Ttl Offset Amt
Corvus Pharmaceuticals, Inc. (CRVS) had Ttl Offset Amt of $0 as of 2026-05-07, per its S-8 filed 2026-05-07.
Financial Statements › Notes
ffd:TtlOffsetAmt · last filed 2026-05-07
- 2026-05-07: Ttl Offset Amt $0.00.
| Period end | Ttl Offset Amt |
|---|---|
| 2026-05-07 | $0.00 S-8 · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |